Published in Am J Hum Genet on January 01, 1993
Antioncogenes and human cancer. Proc Natl Acad Sci U S A (1993) 4.09
A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci U S A (1995) 1.82
Chromosome 1p36 deletions: the clinical phenotype and molecular characterization of a common newly delineated syndrome. Am J Hum Genet (1997) 1.74
Monosomy 1p36. J Med Genet (1999) 1.58
Chromosome 1p terminal deletion: report of new findings and confirmation of two characteristic phenotypes. J Med Genet (1995) 1.47
Screening for submicroscopic chromosome rearrangements in children with idiopathic mental retardation using microsatellite markers for the chromosome telomeres. J Med Genet (1999) 1.31
A constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genes. PLoS One (2008) 1.08
Neuroblastoma tumour genetics: clinical and biological aspects. J Clin Pathol (2001) 1.03
Diagnosis and classification of the small round-cell tumors of childhood. Am J Pathol (1999) 0.88
The genes encoding the peripheral cannabinoid receptor and alpha-L-fucosidase are located near a newly identified common virus integration site, Evi11. J Virol (1997) 0.84
Novel tumor suppressor function of glucocorticoid-induced TNF receptor GITR in multiple myeloma. PLoS One (2013) 0.82
Comparative deletion mapping at 1p31.3-p32.2 implies NFIA responsible for intellectual disability coupled with macrocephaly and the presence of several other genes for syndromic intellectual disability. Mol Cytogenet (2016) 0.77
Neuroblastoma in monozygotic twins--a case of probable twin-to-twin metastasis. Br J Cancer (2001) 0.75
Expression of GITR Enhances Multiple Myeloma Cell Sensitivity to Bortezomib. PLoS One (2015) 0.75
Identification of 1p36 deletion syndrome in patients with facial dysmorphism and developmental delay. Korean J Pediatr (2016) 0.75
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
Variable number of tandem repeat (VNTR) markers for human gene mapping. Science (1987) 25.71
Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics (1989) 19.10
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (1986) 13.96
A genetic linkage map of the human genome. Cell (1987) 13.37
Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (1984) 9.64
Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science (1987) 6.93
Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature (1990) 5.13
Structural evidence for the authenticity of the human retinoblastoma gene. Science (1987) 4.67
Gene for hereditary retinoblastoma assigned to human chromosome 13 by linkage to esterase D. Science (1983) 4.43
Mutation and cancer: neuroblastoma and pheochromocytoma. Am J Hum Genet (1972) 2.99
Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet (1989) 2.56
Parental origin of mutations of the retinoblastoma gene. Nature (1989) 2.26
Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci U S A (1989) 2.25
Cytogenetic features of human neuroblastomas and cell lines. Cancer Res (1981) 2.21
The CEPH consortium linkage map of human chromosome 1. Genomics (1991) 2.09
A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc Natl Acad Sci U S A (1989) 2.02
Chromosomal aberrations in human neuroblastomas. Cancer (1977) 2.01
Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer (1986) 1.93
Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11. Nature (1988) 1.84
Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. Nature (1989) 1.83
Preferential germline mutation of the paternal allele in retinoblastoma. Nature (1989) 1.69
Lack of linkage of familial Wilms' tumour to chromosomal band 11p13. Nature (1988) 1.67
Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res (1984) 1.58
Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene. Cell (1990) 1.52
Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chromosomes Cancer (1989) 1.43
Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet (1989) 1.37
Deletion of chromosome 1p: a short review. Clin Genet (1990) 1.36
Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells. Mol Cell Biol (1989) 1.36
Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res (1992) 1.31
A high-frequency RFLP at the human liver/bone/kidney-type alkaline phosphatase locus. Nucleic Acids Res (1987) 1.22
Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ (1991) 1.19
Constitutional translocation t(1;17)(p36;q12-21) in a patient with neuroblastoma. Genes Chromosomes Cancer (1990) 1.19
A hypervariable repeated sequence on human chromosome 1p36. Hum Genet (1987) 1.15
Tumor-specific loss of 11p15.5 alleles in del11p13 Wilms tumor and in familial adrenocortical carcinoma. Proc Natl Acad Sci U S A (1989) 1.14
Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res (1989) 1.13
Prediction of familial predisposition to retinoblastoma. N Engl J Med (1986) 1.08
Familial neuroblastoma. Case reports, literature review, and etiologic considerations. Cancer (1986) 1.00
Neuroblastoma: clinical significance of genetic abnormalities. Cancer Surv (1990) 0.94
Pvu II RFLP at the human chromosome 1 alpha-L-fucosidase gene locus (FUCA1). Nucleic Acids Res (1986) 0.93
Human atrial natriuretic peptides (ANP) gene locus: BglI RFLP. Nucleic Acids Res (1986) 0.91
Preferential retention of paternal alleles in human retinoblastoma: evidence for genomic imprinting. Cell Growth Differ (1990) 0.90
Localization of the FGR protooncogene on the genetic linkage map of human chromosome 1p. Genomics (1988) 0.87
The human amiloride-sensitive Na+/H+ antiporter: localization to chromosome 1 by in situ hybridization. Cytogenet Cell Genet (1988) 0.83
Cloning of the human genomic amiloride-sensitive Na+/H+ antiporter gene, identification of genetic polymorphisms, and localization on the genetic map of chromosome 1p. Genomics (1990) 0.82
Isolation and mapping of a polymorphic DNA sequence (pCMM8) on chromosome 1p [D1S79]. Nucleic Acids Res (1988) 0.78
Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (1984) 9.64
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med (1999) 9.02
Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med (1985) 7.79
Random-clone strategy for genomic restriction mapping in yeast. Proc Natl Acad Sci U S A (1986) 6.44
Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet (2000) 6.21
Direct transformation of 3T3 cells by Abelson murine leukaemia virus. Nature (1975) 5.97
Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process. Proc Natl Acad Sci U S A (1977) 5.20
Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J Med Genet (1993) 5.16
Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet (1993) 5.00
Purification of human platelet-derived growth factor. Proc Natl Acad Sci U S A (1979) 4.78
A combined linkage-physical map of the human genome. Am J Hum Genet (2004) 4.60
Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci U S A (1979) 4.32
Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol (1998) 3.86
Science and regulation. Mountaintop mining consequences. Science (2010) 3.76
Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. Am J Med Genet (1992) 3.74
A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11. Am J Hum Genet (1992) 3.73
Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry (2009) 3.56
Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst (1989) 3.48
In vitro transformation of lymphoid cells by Abelson murine leukemia virus. Proc Natl Acad Sci U S A (1975) 3.47
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol (1999) 3.35
Separation of sarcoma virus-specific and leukemia virus-specific genetic sequences of Moloney sarcoma virus. Proc Natl Acad Sci U S A (1975) 3.28
Platelet-derived growth factor and the regulation of the mammalian fibroblast cell cycle. Biochim Biophys Acta (1979) 3.26
Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol (1991) 3.16
Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat Genet (1993) 3.11
Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc Natl Acad Sci U S A (1991) 2.77
Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas. Nat Genet (1993) 2.72
An ordered sequence of events is required before BALB/c-3T3 cells become committed to DNA synthesis. Proc Natl Acad Sci U S A (1978) 2.71
Radioimmunoassay of a human serum growth factor for Balb/c-3T3 cells: derivation from platelets. Proc Natl Acad Sci U S A (1977) 2.61
Holoprosencephaly: association with interstitial deletion of 2p and review of the cytogenetic literature. Am J Med Genet (1988) 2.60
The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns (1999) 2.58
Isolation of a cationic polypeptide from human serum that stimulates proliferation of 3T3 cells. Proc Natl Acad Sci U S A (1975) 2.58
Mutations in the homeodomain of the human SIX3 gene cause holoprosencephaly. Nat Genet (1999) 2.57
Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net! Genet Med (2001) 2.57
Localization of gene for human p53 tumour antigen to band 17p13. Nature (1986) 2.56
Mutations in TGIF cause holoprosencephaly and link NODAL signalling to human neural axis determination. Nat Genet (2000) 2.53
Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med (1993) 2.52
Microdeletions of chromosomal region 22q11 in patients with congenital conotruncal cardiac defects. J Med Genet (1993) 2.50
Induction of cell division in medium lacking serum growth factor by SV40. Virology (1971) 2.48
Regions of genomic instability on 22q11 and 11q23 as the etiology for the recurrent constitutional t(11;22). Hum Mol Genet (2000) 2.47
Psychoeducational profile of the 22q11.2 microdeletion: A complex pattern. J Pediatr (1999) 2.38
Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci U S A (1989) 2.25
Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr (2001) 2.24
Cytogenetic features of human neuroblastomas and cell lines. Cancer Res (1981) 2.21
The association of the DiGeorge anomalad with partial monosomy of chromosome 22. J Pediatr (1982) 2.21
Platelet alpha granules contain a growth factor for fibroblasts. Blood (1979) 2.18
Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974-1994. J Pediatr (1997) 2.13
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer (2009) 2.13
Chromosomal aberrations in human neuroblastomas. Cancer (1977) 2.01
Long AT-rich palindromes and the constitutional t(11;22) breakpoint. Hum Mol Genet (2001) 2.00
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies. J Clin Oncol (1996) 1.94
Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol (1994) 1.92
Platelet-derived growth factor-modulated proteins: constitutive synthesis by a transformed cell line. Proc Natl Acad Sci U S A (1981) 1.90
An improved method for G-banding chromosomes after in situ hybridization. Cytogenet Cell Genet (1984) 1.88
Mutations in FAM20C are associated with lethal osteosclerotic bone dysplasia (Raine syndrome), highlighting a crucial molecule in bone development. Am J Hum Genet (2007) 1.88
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study. J Clin Oncol (1998) 1.88
Bifidobacterium longum as a delivery system for gene therapy of chemically induced rat mammary tumors. Breast Cancer Res Treat (2001) 1.88
Detection of deletions and cryptic translocations in Miller-Dieker syndrome by in situ hybridization. Am J Hum Genet (1991) 1.86
High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin Cancer Res (2000) 1.85
Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat Genet (1996) 1.82
Site-specific reciprocal translocation, t(11;22) (q23;q11), in several unrelated families with 3:1 meiotic disjunction. Am J Med Genet (1980) 1.82
A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci U S A (1995) 1.82
A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia. Proc Natl Acad Sci U S A (1984) 1.79
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene (1999) 1.79
Transforming viruses directly reduce the cellular growth requirement for a platelet derived growth factor. J Cell Physiol (1978) 1.79
Tightly clustered 11q23 and 22q11 breakpoints permit PCR-based detection of the recurrent constitutional t(11;22). Am J Hum Genet (2000) 1.78
Identification of a previously unrecognized microdeletion syndrome of 16q11.2q12.2. Clin Genet (2008) 1.77
Mutations in FGFR1 and FGFR2 cause familial and sporadic Pfeiffer syndrome. Hum Mol Genet (1995) 1.76
Deregulation of c-myc by translocation of the alpha-locus of the T-cell receptor in T-cell leukemias. Science (1986) 1.75
Ring chromosome 7 with variable phenotypic expression. Cytogenet Cell Genet (1973) 1.75
Association of chromosome 22q11 deletion with isolated anomalies of aortic arch laterality and branching. J Am Coll Cardiol (2001) 1.75
Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res (1995) 1.72
Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res (2001) 1.71
Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet (1999) 1.71
High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest (1991) 1.70
Cat eye syndrome chromosome breakpoint clustering: identification of two intervals also associated with 22q11 deletion syndrome breakpoints. Cytogenet Cell Genet (1998) 1.70
Absence of p53 gene mutations in primary neuroblastomas. Cancer Res (1993) 1.69
Induction of erythroid leukaemia by Harvey and Kirsten sarcoma viruses. Nature (1975) 1.68
Cloning a balanced translocation associated with DiGeorge syndrome and identification of a disrupted candidate gene. Nat Genet (1995) 1.68
Chromosomal localization of the human elastin gene. Am J Hum Genet (1985) 1.68
Unexpectedly high rate of de novo constitutional t(11;22) translocations in sperm from normal males. Nat Genet (2001) 1.66
Oral-facial-digital syndrome type VI (Váradi syndrome): further clinical delineation. Am J Med Genet (1990) 1.66
Cerebellar atrophy in a patient with velocardiofacial syndrome. J Med Genet (1995) 1.64
Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer Gene Ther (2000) 1.62